?????? ???? ?? ???? ????. Mental and behavioural disorders due to use of other stimulants, including caffeine
Conditions
Interventions
After determining the severity of symptoms and scoring by the physician, Tablet Risperidone 1 mg daily with therapeutic dosage of 1 to 3 mg daily will be administered for 1 week..
Treatment - Drugs
After determining the severity of symptoms and scoring by the physician, Tablet Risperidone 1 mg daily with therapeutic dosage of 1 to 3 mg daily will be administered for 1 week.
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. At least 18 years of age 2. Diagnosis of methamphetamine induced psychosis with structured clinical interview SCID by the approval of a psychiatrist or a psychologist. 3. No anti-psychotic drug use. 4. No other psychological disorders. Exclusion criteria: Patient's unwillingness to continue to participate in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Negative symptoms of psychosis. Timepoint: before intervention and 1 week after intervention. Method of measurement: Scale for the Assessment of negative Symptoms (SANS).;Positive symptoms of psychosis. Timepoint: before intervention and 1 week after intervention. Method of measurement: Scale for the Assessment of Positive Symptoms (SAPS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Arash Mohagheghi
Clinical Psychiatry Research Center
Outcome results
None listed